DEFINITIVE PROXY STATEMENT

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

September 4, 2009

Period of Report

October 6, 2009

Accession Number

0001193125-09-187874

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →